Guru Ownership Trend
Guru Analysis for Harvard Bioscience, Inc. (HBIO)
Harvard Bioscience, Inc. (HBIO), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q1 2026, a total of 1 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $566,976.93.
Top institutional holders include Renaissance Technologies (RenTech).
Institutional sentiment is currently Slightly Bearish. This is evidenced by a $51,359.39 net outflow during the quarter.
On the selling side, Renaissance Technologies (RenTech) reduced exposure by 0.7%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q1 2026)
Guru Consensus (Q1 2026)
FAQs for Harvard Bioscience, Inc. (HBIO)
Major holders include Renaissance Technologies (RenTech) ($493,949). According to the latest reported data, 1 tracked investment managers collectively hold approximately 101,427 shares.
According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $51,359.39, with 0 managers increasing positions and 3 managers reducing holdings.
During the most recent reporting period, 1 managers trimmed their positions, while 2 fully exited HBIO. The total reported sell value was $51,359.39.
No tracked managers opened new positions or increased their holdings in HBIO during the most recent reporting period.